title: How β3 -adrenoceptor-selective is mirabegron?
authors.affiliation: Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany.
authors.forename: Martin C
authors.initials: MC
authors.lastname: Michel
mesh_terms: D058667:Adrenergic beta-3 Receptor Agonists; D006801:Humans; D011941:Receptors, Adrenergic; D022702:Receptors, Adrenergic, beta-3; D053201:Urinary Bladder, Overactive
chemical_list: D058667:Adrenergic beta-3 Receptor Agonists; D011941:Receptors, Adrenergic; D022702:Receptors, Adrenergic, beta-3
references.citation: J Pharmacol Exp Ther. 2013 Oct;347(1):69-79
references.pmid: 23887096
references.citation: Br J Pharmacol. 2016 Feb;173(3):429-30
references.pmid: 26814171
references.citation: Clin Ther. 2012 Oct;34(10):2144-60
references.pmid: 23063375
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2013 Mar;386(3):177-83
references.pmid: 23263450
references.citation: J Urol. 2015 Mar;193(3):921-6
references.pmid: 25254938
references.citation: Am J Physiol Cell Physiol. 2015 Apr 1;308(7):C505-20
references.pmid: 25631871
references.citation: Br J Pharmacol. 2016 Feb;173(3):415-28
references.pmid: 26493129
references.citation: Br J Pharmacol. 2009 Jan;156(1):127-34
references.pmid: 19133996
references.citation: Eur J Pharm Sci. 2012 Aug 15;46(5):381-7
references.pmid: 22430195